The Efficacy of a Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 26, 2022

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions

Drug Resistant EpilepsyMedically Refractory EpilepsyRefractory Epilepsy

Interventions

DRUG

Ketamine Hydrochloride

Three times a week (M, W, F) for 2 consecutive weeks.

Trial Locations (1)

RECRUITING

Mount Sinai Hospital, New York

All Listed Sponsors

lead

Madeline Fields

OTHER